Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - VIVEVE MEDICAL, INC. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
January 7, 2016
Date of Report (Date of Earliest Event Reported)
VIVEVE MEDICAL, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
Yukon Territory |
1-11388 |
04-3153858 |
|
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File No.) |
(I.R.S. Employer Identification No.) |
|
150 Commercial Street Sunnyvale, California 94086 |
|
(Address of Principal Executive Offices) |
|
|
|
(408) 530-1900 |
|
(Issuer’s Telephone Number, Including Area Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition
On January 7, 2016, Viveve Medical, Inc. issued a press release to discuss its results of operations for the quarter ended December 31, 2015. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.
The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.
Item 9.01. Financial Statements and Exhibits.
|
Exhibit No. |
Description |
|
99.1 |
Press Release issued January 7, 2016. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
Date: January 7, 2016 |
By: |
/s/ Patricia Scheller |
|
|
|
|
Patricia Scheller, Chief Executive Officer |
|
|
|
|
|
|
Exhibit Index
|
Exhibit No. |
Description |
|
99.1 |
Press Release issued January 7, 2016. |